Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Early repayment doesn’t necessarily save interest costs. OnDeck is an online lender ... which can range from 1.037 to 1.45 for term loans and 1.10 to 1.30 for lines of credit.

We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street. In this article, we are going to take a look at where ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) stands against the other AI ...

Cedars-Sinai experts are advocating for patients to have access to GLP-1 medications such as semaglutide as a key component to caring for and preventing cardiovascular disease.

If you're struggling to maintain your weight, there are options available that can help. Calocurb is a natural appetite suppressant that can help get you on track.

Weight loss drugs like Ozempic and Wegovy have dominated the diet discussion for the past few years. But this trend leaves many people wondering: What role does weight-loss surgery play in an ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

GSK on Monday also announced a $1 billion deal to acquire another privately ... as the biotech company continues to slash costs. Eli Lilly on Tuesday cut its revenue guidance as it said demand ...